Pt Kalbe Farma Tbk.
(OTC) PTKFY
Pt Kalbe Farma Tbk. Financials at a Glance
Market Cap
$2.79B
Revenue (TTM)
$34.42T
Net Income (TTM)
$3.50T
EPS (TTM)
$0.94
P/E Ratio
13.08
Dividend
$0.44
Beta (Volatility)
0.19 (Low)
Dividend
$0.44
Beta (Volatility)
0.19 (Low)
Price
$12.30
Volume
117
Open
$12.30
Price
$12.30
Volume
117
Open
$12.30
Previous Close
$12.30
Daily Range
$12.30 - $12.30
52-Week Range
$11.44 - $21.16
Dividend
$0.44
Beta (Volatility)
0.19 (Low)
Price
$12.30
Volume
117
Open
$12.30
Previous Close
$12.30
Daily Range
$12.30 - $12.30
52-Week Range
$11.44 - $21.16
PTKFY News
PTKFY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pt Kalbe Farma Tbk.
Industry
Pharmaceuticals
Sector
Health CareEmployees
12,903
CEO
Bernadette Ruth Setiady
Website
www.kalbe.co.idHeadquarters
Jakarta, 10510, ID
PTKFY Financials
Key Financial Metrics (TTM)
Gross Margin
40%
Operating Margin
13%
Net Income Margin
10%
Return on Equity
15%
Return on Capital
17%
Return on Assets
12%
Earnings Yield
7.65%
Dividend Yield
0.04%
Payout Ratio
46.82%
Stock Overview
Market Cap
$2.79B
Shares Outstanding
226.58M
Volume
117
Short Interest
0.00%
Avg. Volume
46
Financials (TTM)
Gross Profit
$12.96T
Operating Income
$4.07T
EBITDA
$4.61T
Operating Cash Flow
$4.79T
Capital Expenditure
$1.25T
Free Cash Flow
$3.53T
Cash & ST Invst.
$4.87T
Total Debt
$559.22B
Pt Kalbe Farma Tbk. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.95T
+13.2%
Gross Profit
$3.41T
+11.7%
Gross Margin
38.10%
N/A
Market Cap
$2.79B
N/A
Market Cap/Employee
$217.03K
N/A
Employees
12,841
N/A
Net Income
$659.68B
+15.1%
EBITDA
$1.09T
+33.2%
Quarterly Fundamentals
Net Cash
$3.66T
+2.4%
Accounts Receivable
$5.81T
+11.9%
Inventory
$7.10T
+9.2%
Long Term Debt
$168.94B
-49.8%
Short Term Debt
$349.74B
-13.6%
Return on Assets
11.61%
N/A
Return on Invested Capital
16.98%
N/A
Free Cash Flow
$687.94B
-22.2%
Operating Cash Flow
$911.25B
-21.1%